[HTML][HTML] Aging-suppressor Klotho: Prospects in diagnostics and therapeutics

CR Abraham, A Li - Ageing Research Reviews, 2022 - Elsevier
Abstract Introduction The protein Klotho (KL) was first discovered in KL-deficient mice, which
developed a syndrome similar to premature aging in humans. Since then, KL has been …

Neurobiology of cannabinoid receptor signaling

B Lutz - Dialogues in clinical neuroscience, 2020 - Taylor & Francis
The endocannabinoid system (ECS) is a highly versatile signaling system within the nervous
system. Despite its widespread localization, its functions within the context of distinct neural …

Biomarkers of bipolar disorder in late life: an evidence-based systematic review

R Chancel, J Lopez-Castroman, E Baca-Garcia… - Current Psychiatry …, 2024 - Springer
Abstract Purpose of Review Review the current evidence on biomarkers for bipolar disorder
in the older adults. We conducted a systematic search of PubMed MEDLINE, PsycINFO, and …

The Importance of α-Klotho in Depression and Cognitive Impairment and Its Connection to Glutamate Neurotransmission—An Up-to-Date Review

P Pańczyszyn-Trzewik, E Czechowska… - International Journal of …, 2023 - mdpi.com
Depression is a serious neuropsychiatric disease affecting an increasing number of people
worldwide. Cognitive deficits (including inattention, poor memory, and decision-making …

Rapid treatments for depression: endocannabinoid system as a therapeutic target

AM Sharafi, S Pakkhesal, A Fakhari… - Neuroscience & …, 2022 - Elsevier
Current first-line treatments for major depressive disorder (MDD), ie, antidepressant drugs
and psychotherapy, show delayed onset of therapeutic effect as late as 2–3 weeks or more …

Hippocampal neuroplasticity, major depression and, not to forget: ECT

A Sartorius, S Karl, D Zilles-Wegner - Molecular Psychiatry, 2024 - nature.com
With this letter we would like to refer to the review on the topic of neuroplasticity,
hippocampus and depression, in which, however, electroconvulsive therapy (ECT) was …

Changes in Tryptophan-Kynurenine Metabolism in Patients with Depression Undergoing ECT—A Systematic Review

TIM Aarsland, JT Instanes, MBR Posserud, A Ulvik… - Pharmaceuticals, 2022 - mdpi.com
The kynurenine pathway of tryptophan (Trp) metabolism generates multiple biologically
active metabolites (kynurenines) that have been implicated in neuropsychiatric disorders. It …

The pattern of change in depressive symptoms and inflammatory markers after electroconvulsive therapy: A systematic review

CY Desfossés, R Peredo, A Chabot, JP Carmel… - The journal of …, 2021 - journals.lww.com
Depression is a major mental health disorder, and its pathophysiology is still largely
unknown, as is the action mechanism of electroconvulsive therapy (ECT). Some evidence …

Non-invasive brain stimulation effects on biomarkers of tryptophan metabolism: a scoping review and meta-analysis

CG Giron, TTZ Lin, RLD Kan, BBB Zhang… - International journal of …, 2022 - mdpi.com
Abnormal activation of the kynurenine and serotonin pathways of tryptophan metabolism is
linked to a host of neuropsychiatric disorders. Concurrently, noninvasive brain stimulation …

Effectiveness and Safety of Flumazenil Augmentation During Electroconvulsive Therapy

L Gistelinck, N Van de Velde, H Tandt… - The Journal of …, 2024 - journals.lww.com
Methods All patients with depressive disorders, treated with flumazenil during a course of
ECT in 2019 in a tertiary hospital, were identified through a retrospective chart review …